All purchased chemicals were used without further purification unless stated otherwise. Solvents were dried over activated 3 Å (acetone) or 4 Å (CH2Cl2, DMF, pyridine, toluene) molecular sieves. THF was distilled on 4 Å molecular sieves shortly before use. Dry MeOH (secco solv) was purchased from Merck. Cation exchange resin DOWEX 50 H + was regenerated by consecutive washing with HCl (3 M), water and dry MeOH. Aqueous solutions of salts were saturated unless stated otherwise. Concentration of organic solutions was performed under reduced pressure < 40 °C. Optical rotations were measured with a Perkin-Elmer 243 B Polarimeter.
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2-(2-Aminoethoxy)ethyl 6-O-phosphocholine-α-D-manno-pyranoside hydrochloride (8).
A solution of 7 (100 mg, 0.137 mmol) in MeOH (16 mL) containing concentrated HCl (80 µL) was hydrogenated over 10% Pd-C (120 mg) for 12 h at rt. The reaction mixture was filtered through Celite and concentrated. The crude product was purified by a pre-packed PD-10 column (H2O) to afford 8 (56 mg, 95%) as a white solid. 
2-(2-Azidoethoxy)ethyl 2,3,4-tri-O-benzyl-6-O-{benzyloxy-2-[N-(tert-butyloxycarbonyl)amino]ethylphosphoryl}-α-D-manno-pyranoside (9).
A solution of 1H-tetrazole in MeCN (0.45 M, 2.3 mL) was added to a solution of 6 (343 mg, 0.609 mmol) and benzyl-N,N,N´,N´-tetraisopropylphosphorodiamidite (534 mg, 1.34 mmol) in dry CH2Cl2 (6.6 mL). The reaction mixture was stirred at rt for 2 h and after cooling to -80 °C, a solution of m-CPBA (316 mg, 1.83 mmol) in dry CH2Cl2 (16 mL) was added. The reaction mixture was stirred for another 1 h at rt and the solution was diluted with CH2Cl2 (10 mL), washed with 10% aq. Na2SO3 (2×15 mL), satd. aq. NaHCO3 (2×15 mL) and H2O (1×15 mL). The organic phase was dried (Na2SO4), concentrated, and the crude product was purified by flash column chromatography (n-hexane/EtOAc 1:1, containing 3% Et3N) to afford compound 9 (diastereomeric mixture on P, 342 mg, 64%) as colorless oil. Rf 0.22 (n-hexane/ 138.39, 138.26, 138.24, 139.19, 138.17, 135.91, 135.87, 135.84, 135.79, 128.53, 128.50, 128.48, 128.39, 128.37, 128.33, 128.09, 127.99, 127.97, 127.91, 127.86, 127.81, 127.77, 127.70, 126.66 and 126.55 (PhC) 
2-(2-Aminoethoxy)ethyl-6-O-{benzyloxy-2-[N-(tert-butyloxycarbonyl)amino]-ethyl-phosphoryl}-α-D-mannopyranoside (10).
A solution of 9 (139 mg, 0.159 mmol) in MeOH (7 mL) was hydrogenated over 10% Pd-C (80 mg) for 12 h at rt. The reaction mixture was filtered through Celite and the filtrate was concentrated and dried to afford 10 (72 mg, 92%) as a colorless solid. Rf 0.31 (CHCl3/MeOH/H2O 2:3:0.2); [α]D 20 +40.2 (c 0.53, MeOH). 1 H NMR (600 MHz, MeOD): δ ~4.83 (beneath the HOD-peak, H-1), 4.20 (ddd, 1H, J6a,6b 11.2, J6a,5 1.9, J6a,P 6. 2 Hz, 3.96 (dt, 1H, J6b, 5 ~ J6b, P 7.1 Hz, , 3.93-3.88 (m, 3H, OCH2), 3.80 (dd, 1H, J1,2 1.7, J3,2 3. 4 Hz, H-2), (m, 6H, OCH2, H-5), 3.69 (dd, 1H, J3,4 9. 4 Hz, 3.58 (app t, 1H, J5, 
2-(2-Azidoethoxy)ethyl 2-O-acetyl-3,4,6-tri-O-benzyl-α-D-manno-pyranoside (12).
Molecular sieves 4 Å (500 mg) were added to a solution of donor 11 (2.50 g, 3.93 mmol) in dry CH2Cl2 (60 mL) and the suspension was stirred for 20 min at rt, then cooled to -40 °C. A solution of 0.196 mmol) in CH2Cl2 (2 mL) was added dropwise under Ar. The reaction was quenched after 5 min by adding triethylamine (54.4 µL). The suspension was warmed to rt, diluted with CH2Cl2 and filtered over CeliteÒ. The filtrate was concentrated and directly applied on a column of silica gel (160 g). Elution with n-hexane/EtOAc 2:1 afforded 12 as colourless syrup. Yield: 2.27 g (96%); α]D 21 +26 (c 1.0, CHCl3) ; 1 H NMR (600 MHz, CDCl3): δ 7. 13 H, PhH ), 2 H, PhH ) 138.39, 138.21, 138.01, 128.32, 128.26, 128.00, 127.81, 127.74, 127.64, 127.56 and 127.53 (PhC) , 97.95 (C-1), 78.08 (C-3), 75.10 (PhCH2), 74.31 (C-4), 73.41 (PhCH2), 71.74 (PhCH2), 71.45 (C-5), 70.07 (CH2OCH2), 70.04 (CH2OCH2), 68.92 (C-6), 68.68 (C-2), 66.84 (OCH2), S7 50.62 (NCH2) and 21.07 (CH3). HRMS ( + ESI-TOF) m/z [M+NH4] + calcd for C33H39N3O8+NH4 + : 623.3075; found: 623.3085.
2-(2-Azidoethoxy)ethyl 3,4,6-tri-O-benzyl-α-D-manno-pyranoside (13).
A solution of 12 (480 mg, 0.792 mmol) was dissolved in dry MeOH (12.5 mL) and treated with 0.1 M methanolic NaOMe (1.58 mL) for 7 h at rt. The solution was made neutral by addition of Dowex H+ ion-exchange resin. The resin was filtered off and the filtrate was concentrated. The residue was subjected to flash chromatography on silica gel (n-hexane/EtOAc 2:1→1:1) which afforded 13 as colourless syrup. Yield: 375 mg (84%). Alternatively, a suspension of 12 (722 mg, 1.19 mmol) and K2CO3 (10 mg, 0.07 mmol) in dry MeOH (5 mL) was stirred for 17 h at rt. Amberlite IR120 resin (H+-form) was added to adjust the pH to7.0. Solids were removed by filtration and the filtrate was concentrated to give 13 (656 mg, 98%); [α]D 20 +47.5 (c 1.0, CHCl3); 1 H NMR (600 MHz, CDCl3): δ 7. 13 H, PhH), 2H, PhH) 34, 138.28, 137.98, 128.49, 128.33, 128.30, 127.90, 127.87, 127.82, 127.80, 127.64 and 127. 53 (PhC) , 99.37 (C-1), 80.11 (C-3), 75.09 (PhCH2), 74.33 (C-4), 73.46 (PhCH2), 71.95 (PhCH2), 71.18 (C-5), 70.10 (CH2OCH2),70.02 (CH2OCH2), 69.04 (C-6), 68.28 (C-2), 66.66 (OCH2) and 50.64 (NCH2). HRMS ( + ESI-TOF) m/z [M+Na] + calcd for C31H37N3O7+Na + : 586.2535; found: 586.2524.
3,4,6-Tri-O-acetyl-2-deoxy-2-trichloroethoxycarbonylamino-b-D-glucopyranosyl-(1→2)-(2-azidoethoxy)ethyl 3,4,6-tri-O-benzyl-α-D-manno-pyranoside (15).
suspension of 13 (1.137 g, 1.82 mmol), donor 14 (2.05 g, 3.64 mmol) and molecular sieves 4Å (1.4 g) in dry CH2Cl2 (30 mL) was stirred under Ar for 20 min at rt, before it was cooled to -40 °C. A solution of TMSO-triflate (50.6 µL) in dry CH2Cl2 (2 mL) was added dropwise and stirring was continued for 6.5 h at -40 °C and for 12 h at +4 °C. Triethylamine (75 µL) was then added under external cooling (ice-bath), the suspension was diluted with CH2Cl2 and filtered over Celite. The filtrate was concentrated and subjected to silica gel chromatography (nhexane/EtOAc 2:1→1:1) resulting in a crude product (2.04 g), purification of which had to be performed by repeated HPLC separations (YMC-column, 250 x 20 mm, n-hexane/EtOAc 3:1→1:1). Pooling of appropriate fractions afforded 15 (996 mg, 53%) and contaminated product fractions (81 mg 53, 138.28, 138.22, 128.35, 128.11, 127.93, 127.70, 127.68 and 127.52 (PhC) A solution of 15 (402 mg, 0.39 mmol) in THF (6 mL) and 1 M aq LiOH (3 mL) was stirred for 5.5 h under reflux. The solution was cooled to rt, diluted with MeOH and made neutral by addition of 1 M HCl. Solvents were removed in vacuo and the residue was twice coevaporated with toluene. The remaining material was dried overnight in vacuo, then dissolved in dry pyridine (6 mL). Acetic anhydride (0.3 mL) and a catalytic amount of DMAP was added and the solution was stirred for 15 h at rt. MeOH (0.5 ml) was then added at 0 °C and stirring was continued for 3 h. The solution was twice co-evaporated with toluene and the residue was dissolved in CH2Cl2. The organic phase was extracted with water, dried (Na2SO4) and concentrated. The residue was purified by silica gel chromatography (n-hexane/EtOAc 1:2.5) which afforded 16 as tiny colourless needles. Yield: 262 mg (75%); mp (crude) 114-118 °C.
[α]D 20 + 11 (c 0.7, CHCl3); 1 H NMR (600 MHz, CDCl3): δ 7.37-7.22 (m, 15H, PhH ), 4.96 (dd, 1H, J3',4' 9.4, J3',2' 11, 170.68, 170.31 and 169.62 (C=O), 148.41, 138.47, 138.45, 138.28, 137.45, 128.40, 128.35, 128.31, 128.24, 127.97, 127.68, 127.67, 127.65, 127.56 and 124.25 (PhC) 4.47 (d, 1H, J 11.2 Hz, PhCH2), 4.42 (d, 1H, J 11.9 Hz, PhCH2), 4.19 (dd, 1H, 4.04 (app. t, 1H, J3, 4 ~ J4, 5 9.3 Hz, , 3.99 (dd, 1H, J2,3 3.1 Hz, H-3), 3.94 (dd, 1H, J6'a, 6'b 11.9, J6'a, 5' 3.8 Hz, 3.84 (dd, 1H, J6'b, 5' 5.0 Hz, , 3.82-3.72 (m, 4H, H-5, H-6a, OCH2, H-3'), 3.68-3.57 (m, 7H, 2 x OCH2, OCH2, H-6b, H-4'), 3. 44 (m, 1H, H-5'), 3.34 (m, 2H, NCH2), 3.29 (br q, 1H, H-2') and 1.82 (s, 3H, NHAc); 13 C NMR (151 MHz, CDCl3): δ 172.68 (C=O), 138.35, 138.89, 137.77, 128.47, 128.46, 128.39, 128.19, 127.98, 127.94, 127.91, 127.74 
2-Acetamido-3,4-di-O-acetyl-6-O-tertbutyldiphenylsilyl-2-deoxy-b-D-glucopyranosyl-(1→2)-2-(2-azidoethoxy)ethyl 3,4,6-tri-O-benzyl-α-D-manno-pyranoside (18)
A solution of 17 (184 mg, 0.24 mmol), diisopropylethylamine (155 mg, 1.2 mmol) and tBDPSCl (85.6 mg, 0.311 mmol) in dry DMF (0.75 mL) was stirred for 3 d at rt. Then pyridine (0.3 mL), a catalytic amount of DMAP and acetic anhydride (0.09 mL) were added and stirring was continued for 2 h at rt. MeOH was added and the mixture was stirred for 1 h. Solvents were removed under reduced pressure and the residue was purified by chromatography (nhexane/EtOAc 1: 2.5) to give 18 ( 138.42, 138.40, 138.16, 135.58, 135.54, 133.20, 133.04, 129.74, 129.70, 128.37, 128.36, 128.30, 128.26, 127.96, 127.74, 127.71, 127.63 and 127.58 
2-Acetamido-3,4-di-O-acetyl-2-deoxy-b-D-glucopyranosyl-(1→2)-2-(2-azidoethoxy)ethyl 3,4,6-tri-O-benzyl-α-D-manno-pyranoside (19)
In a teflon reaction vessel solutions of 1 M acetic acid (1.02 mL) in DMF and 1 M TBAF in THF (124 µL) were added sequentially at 0 °C to a solution of 18 (79 mg, 0.073 mmol) in DMF (2 mL). The solution slowly warmed to rt and was stirred for 15 h.The reaction mixture was then concentrated, diluted with EtOAc and filtered over silica gel. The filtrate was concentrated and the residue was subjected to MPLC (EtOAc) which furnished 38.6 mg (62%) of 19 as syrup;
[α]D 20 +12 (c 1.06, CHCl3); 1 H NMR (600 MHz, CDCl3): δ 7. 15H, PhH), NH), 5.07 (d, 1H, J1', 2' 8.2 Hz, 4.98 (app t, 1H, J3', 4' ~ J4', 5' 9.5 Hz, , JC,P 3.3 Hz, (CH3)3NCH2)], 65.59 (d, JC, P 5.5 Hz, 60.37 (d, JC, P 5.6 Hz, POCH2), 54.68 [app t, JC, P 3.6 Hz, N(CH3) Acetamido-2-deoxy-6-O-phosphorylcholine-b-D-glucopyranosyl-(1→2)-2-(2azidoethoxy)ethyl 3,4,6-tri-O-benzyl-α-D-manno-pyranoside (21) A suspension of the phosphodiester 20 (14 mg, 0.0138 mmol) in dry MeOH (0.7 mL) and a catalytic amount of K2CO3 was stirred for 2 h at rt. The mixture was diluted with MeOH and the pH was adjusted to 6.0 by addition of Dowex 50 cation exchange resin (H + -form). The resin was filtered off and the filtrate was concentrated under reduced pressure to furnish 21 as colorless syrup. Yield: 12.6 mg (98%); [α]D 20 -13.2 (c 0.6, MeOH); 1 H NMR (600 MHz, MeOD): 7. 2H, Ph), 11H, Ph), 2H, Ph), 4.90 (d, 1H, J1, 2 1.8 Hz, 2H, PhCH2), 5H, 2 x PhCH2, H-1'), 4.26 (m, 1H, 4.24 (dd, 1H, J2, 3 3.3, J1, 2 2.0 Hz, 3H, POCH2, 3.90 (dd, 1H, J3, 4 9.4 Hz, , 3.88-3.84 (m, 1H, OCH2), 3.80 (ddd, 1H, J4,5 9.9, J5,6a 1.9, J5,6b 6. 8 Hz, 139.90, 139.55, 129.61, 129.56, 129.44, 129.32, 129.14, 128.92, 128.76 and 128.62 (PhC) 
2-

2-Acetamido-2-deoxy-6-O-phosphorylcholine-b-D-glucopyranosyl-(1→2)-2-(2-aminoethoxy)ethyl-α-D-manno-pyranoside (22)
10% Pd-C catalyst (2 mg) and the phosphodiester 21 (6 mg, 6.7 µmol) were suspended in 1:1 THF/H2O (0.75 mL) containing 1% acetic acid. H2 was bubbled through the suspension under vigorous stirring and kept for 2 days under H2 atmosphere (1 bar) at rt. The catalyst was filtered off and the filtrate was concentrated and co-evaporated with heptane. The residue was dissolved in water and the solution was passed 5 times over Dowex 50 ion exchange resin (H + -form; 400 mg) to remove the byproduct (arising from exchange of the azido group with an OH group). The resin was washed with water and the product was eluted with 2.5% aq NH3. The solvent was removed under reduced pressure and the amine 22 was obtained. Yield: 2.73 mg (64%).
[α]D 20 -2.3 (c 0.5, H2O); 1 H NMR (600 MHz, D2O): d 4.87 (d, 1H, J1,2 1.2 Hz, H-1), 4.57 (d, 1H, J1', 2' 8.5 Hz, 4.30 (m, 2H, POCH2), 4.15 (dd, 1H, J6'a, 6'b 10.8, J6'a, 5' 5. Acetamido-2-deoxy-b-D-glucopyranosyl-(1→2)-2-(2-aminoethoxy) ethyl α-D-mannopyranoside (23) Disaccharide 17 (5 mg, 6.1 µmol) was dissolved in 1:1 THF / H2O (5 mL) containing 1% AcOH and the solution was passed through an H-Cube (Pd-C 10%, 0.2 mL/min; 50 bar H2) twice. The solvents were removed under reduced pressure followed by co-evaporation of acetic acid with heptane and the residue was dried in vacuo. The residue was dissolved in water and the solution was passed over Dowex 50 ion exchange resin (H + -form, 500 mg). The resin was washed with water and the product was eluted with 2.5% aq NH3. The solvent was removed under reduced pressure and the amine 23 was obtained. Yield: 1.7 mg (59%).
2-
[α]D 20 -1.5 (c 0.85, H2O); 1 H NMR (600 MHz, D2O): d 4.86 (d, 1H, J1,2 1.5 Hz, H-1), 4.53 (d, 1H, J1', 2' 8.3 Hz, 4.06 (m, 1H, 3H, OCH2), 3.80 (dd, 1H, J2, 3 3.4, J3, 4 9.7 Hz, 13H, 2.5 x OCH2, 2 802,6 1203,9 1515,6 1604,8 1783,2 943,7 1871,9 1694,2 Compound 3 (Man) 22. Synthesis of BSA-conjugates D-Mannose-BSA conjugate (24). To a solution of the amino compound 3 (15 mg, 0.056 mmol) in 0.1 M aq. NaHCO3 (4 mL) was added a solution of thiophosgene (CSCl2; 10 µL, 0.130 mmol) in CHCl3 (5 mL) and the reaction mixture was vigorously stirred for 2 h at room temperature. Thiophosgene was removed by repeated extraction (3x) with CHCl3 (3 mL) and after removal of the organic layer, residual CHCl3 was evaporated under an air-stream with vigorous stirring. A solution of BSA (18.6 mg, 0.28 µmol) in 0.1 M NaHCO3/0.3 M NaCl (2.5 mL) was added to the aqueous phase and the reaction mixture was stirred for 72 h at room temperature. The solution was dialyzed for 48 h against H2O (2 x 1.5 L) and lyophilized to afford the D-mannose-BSA conjugate 24 (25.4 mg).
S13
HILIC-ELSD chromatograms and spectra
Phosphorylcholine-D-Mannose-BSA conjugate (25).
A solution of compound 8 (17.8 mg, 0.041 mmol) in 0.1 M aq. NaHCO3 (4 mL) and thiophosgene (6.2 µL, 0.082 mmol) in CHCl3 (3.1 mL) was processed and reacted with BSA (13.6 mg, 0.21 µmol) in 0.1 M NaHCO3/0.3 M NaCl (2.5 mL) as described above to give conjugate 25 (24.9 mg).
N-Boc Phosphoethanolamine-D-Mannose-BSA conjugate (26).
A solution of the amino compound 10 (16 mg, 0.033 mmol) in 0.1 M aq. NaHCO3 (4 mL) and thiophosgene (5 µL, 0.066 mmol) in CHCl3 (2.5 mL) was treated and reacted with a solution of BSA (11 mg, 0.17 µmol) in 0.1 M NaHCO3/0.3 M NaCl (2.5 mL) as described to afford 26 (19.9 mg).
Phosphoethanolamine-D-Mannose-BSA conjugate (27).
To a solution of the N-Boc protected conjugate 26 (9.5 mg) in H2O (1.5 mL) was added TFA (40 µL) and the reaction mixture was stirred for 30 min at room temperature. TFA was removed by evaporation and the solution was dialyzed for 48 h against 2 L of H2O and lyophilized to afford the phosphoethanolamine D-mannose-BSA conjugate 27 (10.4 mg).
b-D-GlcNAc-(1→2)-a-D-Mannose-BSA-conjugate (28) A solution of compound 23 (3 mg, 5.5 µmol) in 0.1 M aq. NaHCO3 (2 mL) and thiophosgene (4 µL, 0.052 mmol) in CHCl3 (2 mL) was processed and reacted with BSA (2.1 mg) in 0.1 M NaHCO3/0.3 M NaCl (2.0 mL) as described above to give conjugate 28 (4.1 mg).
6-O-Phosphorylcholine-b-D-GlcNAc-(1→2)-a-D-Mannose-BSA-conjugate (29)
A solution of compound 22 (2 mg, 3.2 µmol) in 0.1 M aq. NaHCO3 (2 mL) and thiophosgene (4 µL, 0.052 mmol) in CHCl3 (2 mL) was processed and reacted with BSA (2.0 mg) in 0.1 M NaHCO3/0.3 M NaCl (2.0 mL) as described above to give conjugate 29 (2.3 mg).
